09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
3544 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601<br />
Podnositelj europske MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
prijave patenta<br />
(71) (51) (97) (54)<br />
Beiersdorf AG, DE A61K 8/44 (2006.01)<br />
EP 2086499 * COSMETIC OR DERMATOLOGICAL PREPARATIONS<br />
A61Q 19/00 (2006.01)<br />
WITH A CONTENT OF 2-ISOPROPYL-5- METHYL-<br />
CYCLOHEXANECARBONYL-D-ALANINE METHYL<br />
ESTER AND ONE OR MORE SKIN MOISTURISING<br />
Beiersdorf AG, DE A61K 8/44 (2006.01)<br />
A61Q 19/00 (2006.01)<br />
EP 2086500 *<br />
AGENTS<br />
COSMETIC OR DERMATOLOGICAL PREPARATIONS<br />
WITH COMBINATIONS OF METHYL (R)-2-Ý((1R, 2S,<br />
5R)-2-ISOPROPYL-5-METHYL-<br />
CYCLOHEXANECARBONYL)-AMINO¨-PROPIONATE<br />
AND ONE OR MORE LIGHT PROTECTIVE FILTER<br />
SUBSTANCES<br />
Berthold Sichert GmbH, DE H02B 1/50 (2006.01)<br />
EP 2087565 * TWO-PIECE INNER BODY<br />
BIOPROJET, FR C07D 271/06 (2006.01)<br />
C07D 413/10 (2006.01)<br />
EP 2014653 Novel dicarboxylic acid derivatives as S1P1 receptor<br />
agonists<br />
C07D 413/14 (2006.01)<br />
A61K 31/4245 (2006.01)<br />
A61P 29/00 (2006.01)<br />
A61P 37/06 (2006.01)<br />
Blomkvist, Ove, NO C02F 11/14 (2006.01)<br />
EP 2086892 * METHOD AND DEVICE FOR TREATMENT OF LIQUID<br />
B01F 7/16 (2006.01)<br />
MATERIALS BASED ON ORGANIC WASTE<br />
C05F 7/00 (2006.01)<br />
PRODUCTS<br />
Blücher GmbH, DE F27B 7/22 (2006.01) EP 1748269 Rotary furnace for manufacturing activated carbon<br />
Bocquet, Gwénolé, FR G02B 27/22 (2006.01)<br />
EP 2100181 * SINGLE AND DOUBLE IMMATERIAL ELLIPSOID<br />
Boehringer Ingelheim International<br />
EP 2<strong>09</strong>4271 * DRUG COMBINATIONS FOR TREATING AIRWAY<br />
GmbH, DE<br />
DISEASES<br />
Boehringer Ingelheim Pharma GmbH &<br />
Co. KG, DE<br />
BOEHRINGER INGELHEIM<br />
VETMEDICA GMBH, DE<br />
A61K 31/536 (2006.01)<br />
A61P 11/00 (2006.01)<br />
A61P 9/06 (2006.01)<br />
A61P 9/04 (2006.01)<br />
A61P 17/02 (2006.01)<br />
A61P 17/04 (2006.01)<br />
A61K 31/536 (2006.01)<br />
A61P 11/00 (2006.01)<br />
A61P 9/06 (2006.01)<br />
A61P 9/04 (2006.01)<br />
A61P 17/02 (2006.01)<br />
A61P 17/04 (2006.01)<br />
A61K 31/41 (2006.01)<br />
A61K 31/4184 (2006.01)<br />
A61P 9/00 (2006.01)<br />
A61P 13/12 (2006.01)<br />
A61K 45/06 (2006.01)<br />
BOEHRINGER INGELHEIM<br />
A61K 47/48 (2006.01)<br />
VETMEDICA GMBH, DE<br />
A61K 9/00 (2006.01)<br />
BONGIOVI, Anthony, US H04B 1/00 (2006.01)<br />
BRAHMS Aktiengesellschaft, DE G01N 33/68 (2006.01)<br />
EP 2<strong>09</strong>4271 *<br />
EP 2086535 *<br />
EP 2089060 *<br />
EP 2<strong>09</strong>5513 *<br />
EP 2089718 *<br />
BRAHMS Aktiengesellschaft, DE G01N 33/50 (2006.01)<br />
EP 2<strong>09</strong>7748 *<br />
BRAHMS Aktiengesellschaft, DE G01N 33/68 (2006.01)<br />
EP 2100145 *<br />
Bristol-Myers Squibb Company, US C07D 401/12 (2006.01)<br />
EP 2086963 *<br />
C07D 401/14 (2006.01)<br />
C07D 417/14 (2006.01)<br />
C07K 5/00 (2006.01)<br />
A61K 31/47<strong>09</strong> (2006.01)<br />
A61P 31/14 (2006.01)<br />
Bristol-Myers Squibb Company, US C07D 4<strong>09</strong>/04 (2006.01)<br />
EP 2086967 *<br />
C07D 231/56 (2006.01)<br />
C07D 237/32 (2006.01)<br />
C07D 239/88 (2006.01)<br />
C07D 487/04 (2006.01)<br />
C07D 495/04 (2006.01)<br />
C07D 498/04 (2006.01)<br />
C07K 5/08 (2006.01)<br />
Bristol-Myers Squibb Company, US C07D 471/04 (2006.01)<br />
EP 2086975 *<br />
A61K 31/4375 (2006.01)<br />
A61P 3/06 (2006.01)<br />
Bristol-Myers Squibb Company, US C07D 487/04 (2006.01)<br />
EP 2086980 *<br />
C07D 498/04 (2006.01)<br />
A61K 31/407 (2006.01)<br />
A61P 31/12 (2006.01)<br />
Bristol-Myers Squibb Company, US C07K 5/08 (2006.01)<br />
EP 2086994 *<br />
C07K 5/06 (2006.01)<br />
A61K 38/06 (2006.01)<br />
A61P 31/14 (2006.01)<br />
DRUG COMBINATIONS FOR TREATING AIRWAY<br />
DISEASES<br />
ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE<br />
TREATMENT OF SYSTEMIC DISEASES IN CATS<br />
LIQUID PREPARATION COMPRISING A COMPLEX<br />
OF PIMOBENDAN AND CYCLODEXTRIN<br />
SYSTEM AND METHOD FOR DIGITAL SIGNAL<br />
PROCESSING<br />
DIAGNOSIS AND RISK STRATIFICATION OF<br />
INFECTIONS AND CHRONIC DISEASES OF THE<br />
RESPIRATORY TRACT AND LUNGS BY MEANS OF<br />
PROVASOPRESSIN, PARTICULARLY COPEPTIN OR<br />
NEUROPHYSIN II<br />
DIAGNOSIS AND RISK ASSESSMENT OF<br />
PANCREATIC DIABETES USING MR-PROADM<br />
DIAGNOSIS AND RISK STRATIFICATION OF<br />
CARDIAC INSUFFICIENCY USING NEUROPHYSIN<br />
HEPATITIS C VIRUS INHIBITORS<br />
INHIBITORS OF HEPATITIS C VIRUS<br />
7,8-DIHYDRO-1,6-NAPHTHYRIDIN-5(6H)-ONES AND<br />
RELATED BICYCLIC COMPOUNDS AS INHIBITORS<br />
OF DIPEPTIDYL PEPTIDASE IV AND METHODS<br />
MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS<br />
INHIBITORS<br />
INHIBITORS OF HEPATITIS C VIRUS<br />
ISSN 1331-2030